{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:19:39Z","timestamp":1777623579242,"version":"3.51.4"},"reference-count":33,"publisher":"Japanese Society of Internal Medicine","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,10,1]]},"DOI":"10.2169\/internalmedicine.4613-24","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T18:09:31Z","timestamp":1744394971000},"page":"2823-2828","source":"Crossref","is-referenced-by-count":2,"title":["Association of Obesity, Visceral Fat Accumulation, and Dyslipidemia with the Risk of Chronic Kidney Disease"],"prefix":"10.2169","volume":"64","author":[{"given":"Yui","family":"Yoshida","sequence":"first","affiliation":[{"name":"Department of Biostatistics, Graduate School of Medicine, The University of Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Hagiwara","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Graduate School of Medicine, The University of Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari","family":"Ito","sequence":"additional","affiliation":[{"name":"AI\/Data Science Social Implementation Laboratory, Research and Development Initiative, Chuo University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Nishi","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Endocrinology, The University of Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Matsuyama","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Graduate School of Medicine, The University of Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 395: 709-733, 2020.","DOI":"10.1016\/S0140-6736(20)30045-3"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Solomon SD, Lin J, Solomon CG, et al; the Prevention of Events With ACE Inhibition (PEACE) Investigators. Influence of albuminuria on cardiovascular risk in patients with stable coronary artery disease. Circulation 116: 2687-2693, 2007.","DOI":"10.1161\/CIRCULATIONAHA.107.723270"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Abramson JL, Jurkovitz CT, Vaccarino V, Weintraub WS, McClellan W. Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC Study. Kidney Int 64: 610-615, 2003.","DOI":"10.1046\/j.1523-1755.2003.00109.x"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Ibsen H, Olsen MH, Wachtell K, et al. Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study. Hypertension 45: 198-202, 2005.","DOI":"10.1161\/01.HYP.0000154082.72286.2a"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Hanafusa N, Abe M, Joki N, et al. 2021 annual dialysis data report, JSDT Renal Data Registry. Nihon Toseki Igakkai Zasshi (J Jpn Soc Dial Ther) 55: 665-723, 2022 (in Japanese).","DOI":"10.4009\/jsdt.55.665"},{"key":"6","unstructured":"6. Ministry of Health, Labour and Welfare. Overview of national health care expenditures (2020) [Internet]. [cited 2024 Aug 25]. Available from: https:\/\/www.mhlw.go.jp\/toukei\/saikin\/hw\/k-iryohi\/20\/index.html"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358: 2560-2572, 2008.","DOI":"10.1056\/NEJMoa0802987"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Yamagata K, Ishida K, Sairenchi T, et al. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int 71: 159-166, 2007.","DOI":"10.1038\/sj.ki.5002017"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Hanratty R, Chonchol M, Havranek EP, et al. Relationship between blood pressure and incident chronic kidney disease in hypertensive patients. Clin J Am Soc Nephrol 6: 2605-2611, 2011.","DOI":"10.2215\/CJN.02240311"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Foster MC, Hwang SJ, Larson MG, et al. Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study. Am J Kidney Dis 52: 39-48, 2008.","DOI":"10.1053\/j.ajkd.2008.03.003"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Stefansson VTN, Schei J, Solbu MD, Jenssen TG, Melsom T, Eriksen BO. Metabolic syndrome but not obesity measures are risk factors for accelerated age-related glomerular filtration rate decline in the general population. Kidney Int 93: 1183-1190, 2018.","DOI":"10.1016\/j.kint.2017.11.012"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Nguyen A, Khafagy R, Gao Y, et al. Association between obesity and chronic kidney disease: multivariable mendelian randomization analysis and observational data from a bariatric surgery cohort. Diabetes 72: 496-510, 2023.","DOI":"10.2337\/db22-0696"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kramer H, Gutierrez OM, Judd SE, et al. Waist circumference, body mass index, and ESRD in the REGARDS (reasons for geographic and racial differences in Stroke) study. Am J Kidney Dis 67: 62-69, 2016.","DOI":"10.1053\/j.ajkd.2015.05.023"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ryu S, Chang Y, Woo HY, et al; the CKD Prognosis Consortium (CKD-PC). Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes. Am J Kidney Dis 53: 59-69, 2009.","DOI":"10.1053\/j.ajkd.2008.07.027"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Chang AR, Grams ME, Ballew SH, et al; the CKD Prognosis Consortium (CKD-PC). Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium. BMJ 364: k5301, 2019.","DOI":"10.1136\/bmj.k5301"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 65: 1870-1876, 2004.","DOI":"10.1111\/j.1523-1755.2004.00582.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Elsayed EF, Sarnak MJ, Tighiouart H, et al. Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis 52: 29-38, 2008.","DOI":"10.1053\/j.ajkd.2008.02.363"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. de Boer IH, Katz R, Fried LF, et al. Obesity and change in estimated GFR among older adults. Am J Kidney Dis 54: 1043-1051, 2009.","DOI":"10.1053\/j.ajkd.2009.07.018"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Soohoo M, Hashemi L, Hsiung JT, et al. Association of serum triglycerides and renal outcomes among 1.6 million US veterans. Nephron 146: 457-468, 2022.","DOI":"10.1159\/000522388"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Halbesma N, Brantsma AH, Bakker SJ, et al; the PREVEND study group. Gender differences in predictors of the decline of renal function in the general population. Kidney Int 74: 505-512, 2008.","DOI":"10.1038\/ki.2008.200"},{"key":"21","unstructured":"21. Matsuzawa Y, Ikeda Y, Katayama S, et al. Definition and the diagnostic standard for metabolic syndrome - Committee to Evaluate Diagnostic Standards for Metabolic Syndrome. Nihon Naika Gakkai Zasshi (J Jpn Soc Intern Med) 94: 794-809, 2005 (in Japanese)."},{"key":"22","unstructured":"22. Japanese Society of Nephrology. Special issue: clinical practice guidebook for diagnosis and treatment of chronic kidney disease 2012. Nihon Jinzo Gakkai Zasshi (Jpn J Nephrol) 54: 1034-1191, 2012 (in Japanese)."},{"key":"23","unstructured":"23. Ministry of Health, Labour and Welfare. The national health and nutrition survey in Japan [Internet]. [cited 2024 Aug 25]. Available from: https:\/\/www.mhlw.go.jp\/bunya\/kenkou\/kenkou_eiyou_chousa.html"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Matsushita K, Selvin E, Bash LD, Franceschini N, Astor BC, Coresh J. Change in estimated GFR associates with coronary heart disease and mortality. J Am Soc Nephrol 20: 2617-2624, 2009.","DOI":"10.1681\/ASN.2009010025"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Eriksen BO, Ingebretsen OC. The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int 69: 375-382, 2006.","DOI":"10.1038\/sj.ki.5000058"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Ann Intern Med 144: 21-28, 2006.","DOI":"10.7326\/0003-4819-144-1-200601030-00006"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Wang Y, Chen X, Song Y, Caballero B, Cheskin LJ. Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney Int 73: 19-33, 2008.","DOI":"10.1038\/sj.ki.5002586"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Watanabe H, Obata H, Watanabe T, Sasaki S, Nagai K, Aizawa Y. Metabolic syndrome and risk of development of chronic kidney disease: the Niigata preventive medicine study. Diabetes Metab Res Rev 26: 26-32, 2010.","DOI":"10.1002\/dmrr.1058"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Navaneethan SD, Schold JD, Kirwan JP, et al. Metabolic syndrome, ESRD, and death in CKD. Clin J Am Soc Nephrol 8: 945-952, 2013.","DOI":"10.2215\/CJN.09870912"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Huh JH, Yadav D, Kim JS, et al. An association of metabolic syndrome and chronic kidney disease from a 10-year prospective cohort study. Metabolism 67: 54-61, 2017.","DOI":"10.1016\/j.metabol.2016.11.003"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Sarafidis PA, Ruilope LM. Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications. Am J Nephrol 26: 232-244, 2006.","DOI":"10.1159\/000093632"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Wahba IM, Mak RH. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease. Clin J Am Soc Nephrol 2: 550-562, 2007.","DOI":"10.2215\/CJN.04071206"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Jung CH, Lee MJ, Kang YM, et al. The risk of chronic kidney disease in a metabolically healthy obese population. Kidney Int 88: 843-850, 2015.","DOI":"10.1038\/ki.2015.183"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/19\/64_4613-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T03:20:01Z","timestamp":1759548001000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/19\/64_4613-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":33,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4613-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"article-number":"4613-24"}}